Randomized, placebo-controlled, double-blind trial of long-acting release octreotide for treatment of Graves’ ophthalmopathy - Stan, M N; Garrity, J A; Bradley, E A; Woog, J J; Bahn, M M; Brennan, M D; Bryant, S C; Achenbach, S J; Bahn, R S (J Clin Endocrinol Metab, 2006)